Howard G. Welgus sold $127K of ARQT stock

Howard G. Welgus, Dir of Arcutis Biotherapeutics, Inc. (ARQT), sold 4,728 shares of ARQT stock worth $127K, per an SEC Form 4 filed Oct 19, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 15, 2026, 4 days before it was made public.

ARQT has moved -12.2% since the trade date, from $29.10 to $25.55 (Nov 6, 2026 close).